Regulation of the Pro-Angiogenic Microenvironment by Carboxyamido-Triazole

Vyta Kulpa Oliver, Angela M. Patton, Sudhen Desai, Dominique Lorang, Steven K. Libutti, Elise C. Kohn

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Anti-angiogenic agents regulate tumor growth by inhibiting endothelial cell proliferation and invasion. Carboxyamido-triazole (CAI), an inhibitor of non-voltage-operated calcium entry and calcium influx-mediated pathways, has angiogenesis and invasion inhibitory activity. We hypothesized that CAI may express its anti-angiogenic effects through negative regulation of pro-angiogenic cytokine production and/or function. In vivo, orally administered CAI prevented A2058 human melanoma xenograft growth and concomitantly resulted in a marked reduction in circulating vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8). In vitro, A2058 cell secretion of VEGF was inhibited by CAI treatment under limiting micronutrient conditions that approximate the tumor microenvironment, media restriction, and acidification to pH 6.8 (P = 0.0003 and P = 0.0006, respectively). VEGF and HIF-1α message and protein were also reduced by CAI treatment. Oral CAI treatment reduced vascular ingrowth in vivo into VEGF-containing Matrigel plugs. Commensurate with those findings, human umbilical vein endothelial cell (HUVEC) migration towards VEGF was reduced below background by exposure to CAI in the migration chamber (P < 0.0001). An 88% reduction in circulating IL-8 concentration was measured in CAI-treated animals. However, IL-8 protein secretion and gene expression were increased by CAI treatment in culture (P ≤ 0.01), where CAI caused a dose-dependent acidification of the culture milieu (P ≤ 0.005). This paradox suggests that IL-8 production in vitro may be more sensitive to ambient pH than cytosolic calcium. These observations suggest that CAI inhibition of tumor cell VEGF production and endothelial cell response to VEGF results in disruption of signaling between the tumor and its microenvironment, causing a net anti-angiogenic effect.

Original languageEnglish (US)
Pages (from-to)139-148
Number of pages10
JournalJournal of Cellular Physiology
Volume197
Issue number1
DOIs
StatePublished - Oct 2003
Externally publishedYes

Fingerprint

carboxyamido-triazole
Vascular Endothelial Growth Factor A
Interleukin-8
Tumors
Endothelial cells
Tumor Microenvironment
Acidification
Calcium
Endothelial Cells
Micronutrients

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Oliver, V. K., Patton, A. M., Desai, S., Lorang, D., Libutti, S. K., & Kohn, E. C. (2003). Regulation of the Pro-Angiogenic Microenvironment by Carboxyamido-Triazole. Journal of Cellular Physiology, 197(1), 139-148. https://doi.org/10.1002/jcp.10350

Regulation of the Pro-Angiogenic Microenvironment by Carboxyamido-Triazole. / Oliver, Vyta Kulpa; Patton, Angela M.; Desai, Sudhen; Lorang, Dominique; Libutti, Steven K.; Kohn, Elise C.

In: Journal of Cellular Physiology, Vol. 197, No. 1, 10.2003, p. 139-148.

Research output: Contribution to journalArticle

Oliver, VK, Patton, AM, Desai, S, Lorang, D, Libutti, SK & Kohn, EC 2003, 'Regulation of the Pro-Angiogenic Microenvironment by Carboxyamido-Triazole', Journal of Cellular Physiology, vol. 197, no. 1, pp. 139-148. https://doi.org/10.1002/jcp.10350
Oliver, Vyta Kulpa ; Patton, Angela M. ; Desai, Sudhen ; Lorang, Dominique ; Libutti, Steven K. ; Kohn, Elise C. / Regulation of the Pro-Angiogenic Microenvironment by Carboxyamido-Triazole. In: Journal of Cellular Physiology. 2003 ; Vol. 197, No. 1. pp. 139-148.
@article{3a9484c973f94b9594fcc18cddc76569,
title = "Regulation of the Pro-Angiogenic Microenvironment by Carboxyamido-Triazole",
abstract = "Anti-angiogenic agents regulate tumor growth by inhibiting endothelial cell proliferation and invasion. Carboxyamido-triazole (CAI), an inhibitor of non-voltage-operated calcium entry and calcium influx-mediated pathways, has angiogenesis and invasion inhibitory activity. We hypothesized that CAI may express its anti-angiogenic effects through negative regulation of pro-angiogenic cytokine production and/or function. In vivo, orally administered CAI prevented A2058 human melanoma xenograft growth and concomitantly resulted in a marked reduction in circulating vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8). In vitro, A2058 cell secretion of VEGF was inhibited by CAI treatment under limiting micronutrient conditions that approximate the tumor microenvironment, media restriction, and acidification to pH 6.8 (P = 0.0003 and P = 0.0006, respectively). VEGF and HIF-1α message and protein were also reduced by CAI treatment. Oral CAI treatment reduced vascular ingrowth in vivo into VEGF-containing Matrigel plugs. Commensurate with those findings, human umbilical vein endothelial cell (HUVEC) migration towards VEGF was reduced below background by exposure to CAI in the migration chamber (P < 0.0001). An 88{\%} reduction in circulating IL-8 concentration was measured in CAI-treated animals. However, IL-8 protein secretion and gene expression were increased by CAI treatment in culture (P ≤ 0.01), where CAI caused a dose-dependent acidification of the culture milieu (P ≤ 0.005). This paradox suggests that IL-8 production in vitro may be more sensitive to ambient pH than cytosolic calcium. These observations suggest that CAI inhibition of tumor cell VEGF production and endothelial cell response to VEGF results in disruption of signaling between the tumor and its microenvironment, causing a net anti-angiogenic effect.",
author = "Oliver, {Vyta Kulpa} and Patton, {Angela M.} and Sudhen Desai and Dominique Lorang and Libutti, {Steven K.} and Kohn, {Elise C.}",
year = "2003",
month = "10",
doi = "10.1002/jcp.10350",
language = "English (US)",
volume = "197",
pages = "139--148",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Regulation of the Pro-Angiogenic Microenvironment by Carboxyamido-Triazole

AU - Oliver, Vyta Kulpa

AU - Patton, Angela M.

AU - Desai, Sudhen

AU - Lorang, Dominique

AU - Libutti, Steven K.

AU - Kohn, Elise C.

PY - 2003/10

Y1 - 2003/10

N2 - Anti-angiogenic agents regulate tumor growth by inhibiting endothelial cell proliferation and invasion. Carboxyamido-triazole (CAI), an inhibitor of non-voltage-operated calcium entry and calcium influx-mediated pathways, has angiogenesis and invasion inhibitory activity. We hypothesized that CAI may express its anti-angiogenic effects through negative regulation of pro-angiogenic cytokine production and/or function. In vivo, orally administered CAI prevented A2058 human melanoma xenograft growth and concomitantly resulted in a marked reduction in circulating vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8). In vitro, A2058 cell secretion of VEGF was inhibited by CAI treatment under limiting micronutrient conditions that approximate the tumor microenvironment, media restriction, and acidification to pH 6.8 (P = 0.0003 and P = 0.0006, respectively). VEGF and HIF-1α message and protein were also reduced by CAI treatment. Oral CAI treatment reduced vascular ingrowth in vivo into VEGF-containing Matrigel plugs. Commensurate with those findings, human umbilical vein endothelial cell (HUVEC) migration towards VEGF was reduced below background by exposure to CAI in the migration chamber (P < 0.0001). An 88% reduction in circulating IL-8 concentration was measured in CAI-treated animals. However, IL-8 protein secretion and gene expression were increased by CAI treatment in culture (P ≤ 0.01), where CAI caused a dose-dependent acidification of the culture milieu (P ≤ 0.005). This paradox suggests that IL-8 production in vitro may be more sensitive to ambient pH than cytosolic calcium. These observations suggest that CAI inhibition of tumor cell VEGF production and endothelial cell response to VEGF results in disruption of signaling between the tumor and its microenvironment, causing a net anti-angiogenic effect.

AB - Anti-angiogenic agents regulate tumor growth by inhibiting endothelial cell proliferation and invasion. Carboxyamido-triazole (CAI), an inhibitor of non-voltage-operated calcium entry and calcium influx-mediated pathways, has angiogenesis and invasion inhibitory activity. We hypothesized that CAI may express its anti-angiogenic effects through negative regulation of pro-angiogenic cytokine production and/or function. In vivo, orally administered CAI prevented A2058 human melanoma xenograft growth and concomitantly resulted in a marked reduction in circulating vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8). In vitro, A2058 cell secretion of VEGF was inhibited by CAI treatment under limiting micronutrient conditions that approximate the tumor microenvironment, media restriction, and acidification to pH 6.8 (P = 0.0003 and P = 0.0006, respectively). VEGF and HIF-1α message and protein were also reduced by CAI treatment. Oral CAI treatment reduced vascular ingrowth in vivo into VEGF-containing Matrigel plugs. Commensurate with those findings, human umbilical vein endothelial cell (HUVEC) migration towards VEGF was reduced below background by exposure to CAI in the migration chamber (P < 0.0001). An 88% reduction in circulating IL-8 concentration was measured in CAI-treated animals. However, IL-8 protein secretion and gene expression were increased by CAI treatment in culture (P ≤ 0.01), where CAI caused a dose-dependent acidification of the culture milieu (P ≤ 0.005). This paradox suggests that IL-8 production in vitro may be more sensitive to ambient pH than cytosolic calcium. These observations suggest that CAI inhibition of tumor cell VEGF production and endothelial cell response to VEGF results in disruption of signaling between the tumor and its microenvironment, causing a net anti-angiogenic effect.

UR - http://www.scopus.com/inward/record.url?scp=0141483520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141483520&partnerID=8YFLogxK

U2 - 10.1002/jcp.10350

DO - 10.1002/jcp.10350

M3 - Article

C2 - 12942550

AN - SCOPUS:0141483520

VL - 197

SP - 139

EP - 148

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 1

ER -